The Foundational Role and Best Practice Dimensions of Sensor-Based Glycemic Monitoring in the Managed Care Setting
_{A Practical Roadmap for Establishing and Deploying CGM Across the Spectrum of Diabetes Care}

The Foundational Role of Sensor-Based CGM as a Best Practice Strategy for Managing Persons with Diabetes in the Managed Care Setting

Vivian Fonseca, FRCP, MD

Video

Improving Overall Resource Utilization, Reducing Costs and Complications, and Improving Glycemic Metrics with Sensor-Based CGM

Irl Hirsch, MD

Video

The Evolving Role of Sensor-Based CGM as a Best Practice Strategy for Managing Persons with Type 2 Diabetes on Oral Therapy

Eden Miller, DO

Strategies for Incorporating CGM into Managed Care Medical Practice<br><sub>Real-World Tactics for Overcoming Barriers and Improving Utilization of Sensor-Based CGM in the Managed Care Practice Setting</sub>

Video

Strategies for Incorporating CGM into Managed Care Medical Practice
_{Real-World Tactics for Overcoming Barriers and Improving Utilization of Sensor-Based CGM in the Managed Care Practice Setting}

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Program Medium
Internet-based program

Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period April 21, 2022 through April 21, 2024 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view the activity, totaling 2.0 hours, to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out CME certificate.

Estimated Time to Complete Educational Activity
2.0 hours. Physicians must study the enduring activity, and are expected to view every segment to successfully complete the activity and earn CME credit.

Course Overview
In this web-based program, physicians will learn how recent developments in sensor-based continuous glucose monitoring have advanced the management of Type 2 and Type 1 diabetes.

Release Date
April 21, 2022

Expiration Date
April 21, 2024

Intended Audience
This complimentary CME educational activity is designed for all healthcare providers (HCPs) involved in developing, delivering, consulting, and monitoring care for patients with type 2 or type 1 diabetes, including endocrinologists, diabetes specialists, primary care physicians, and related clinicians.

Registration
Participation in this activity is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support
This activity is supported by an independent medical education grant from Abbott Diabetes Care.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Chan Medical School and CMEducation Resources, LLC. The University of Massachusetts Chan Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement
The University of Massachusetts Chan Medical School, Office of Continuing Medical Education designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure
It is the policy of the University of Massachusetts Chan Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Chan Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosure
Vivian Fonseca, MD – Program Chair
Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA

Consulting: Takeda, Novo Nordisk, Sanofi – Aventis, Eli, Abbott, AstraZeneca, Intarcia, Asahi
Research Support (To Tulane): Grants from Bayer and Boehringer Ingelheim
Stock Options: Microbiome Technologies, Insulin Algorithms, BRAVO4Health.
Stock: Amgen

Irl Hirsch, MD
Professor of Medicine
Diabetes Treatment and Teaching Chair
University of Washington Medical Center
Medical Director
UWMC Diabetes Care Center
Seattle, Washington

Research: Medtronic, Insulet, Beta Bionics
Consulting: Abbott Diabetes Care, Bigfoot, Roche, GWave

Eden Miller, DO
Executive Director and Co-Founder
Diabetes Nation
High Lakes Health Care
St. Charles Hospital
Bend, Oregon

Advisor or consultant: Abbott Laboratories; AstraZeneca Pharmaceuticals LP; Becton, Dickinson and Company; Intarcia Therapeutics, Inc.; Janssen Pharmaceuticals; Lilly; Novo Nordisk; Sanofi Aventis
Speaker or Speakers Bureau: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceuticals; Lilly; Novo Nordisk

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Cleveland Clinic Endocrinology and Metabolist Institute
Cleveland, OH

Advisor or consultant for: Diatribe; Lilly; Sanofi; Undermyfork
Speaker or a member of a speakers bureau for: Abbott; Bayer; Dexcom; Insulet; Medtronic; Novo Nordisk; Xeris Pharmaceuticals

Program Managers and Web Editor Disclosure
Program Managers Gideon Bosker, MD and Denise Leary have nothing to disclose.

Educational Objectives
Upon completion of this activity, participants will be able to:

Outline and discuss the evidentiary basis for senor/patch-based CGM technologies, and how to best Implement CGM-based technologies into their overall diabetes care plans for persons with diabetes within the managed care environment
Analyze the rationale and evidence for pharmacists recommending and facilitating adoption of technology-centric CGM monitoring and treatment plans using patch-and-reader-based technologies in the managed care setting
Compare and contrast available CGM-facilitating monitoring technologies-including their inclusion as a pharmacy or medical benefit in a managed care setting-and pair such technologies with optimal patient profiles.
Discuss the foundational role and practical implementation perspective of sensor-based continuous glucose monitoring in the managed care setting to optimize clinical outcomes, target goal attainment, and comprehensive health metrics in persons across the diabetes spectrum, especially persons with Type 2 diabetes.
Discuss the rationale and practical aspects of applying new CGM technologies and capabilities-including improved device accuracy, alarm features, and integration into electronic health records (EHRs)-to managed care, with a special focus on all persons with diabetes, including those not on insulin therapy

Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.

Privacy Policy
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

· We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.

· For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.

· We may use the Information to send you information about other CME activities that CMEducation Resources is offering.

· If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.

· You should check this privacy policy periodically to see whether we have made any changes.

Disclaimer
Copyright © 2022 by CMEducation Resources, LLC All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.
Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations geenerated by professional, academic societies, colleges, or associations.

The Foundational Role and Best Practice Dimensions of Sensor-Based Glycemic Monitoring in the Managed Care SettingA Practical Roadmap for Establishing and Deploying CGM Across the Spectrum of Diabetes Care

The Foundational Role and Best Practice Dimensions of Sensor-Based Glycemic Monitoring in the Managed Care Setting
_{A Practical Roadmap for Establishing and Deploying CGM Across the Spectrum of Diabetes Care}